TSX:APTX

Apotex Health Corp. · TSX · Healthcare · CAD · FY for 2026

Figures on this page computed 2026-11-08 12:26 UTC

Last close

n/aCAD

Market data

21.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CAD
- computed
- Computed from the filing for 2026
19.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
10.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
13.2%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CAD
- computed

What it pays out is the furthest below its sector's middle: 0.10 against 0.54 on the market's range.

Five bars, one line

lens 7 of 9

1.07x

2.96x

1.12x

1.31x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2026

Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2026

Sales1.07x
Its own average over 3 years, 3.26B.
Profit2.96x
Its own average over 3 years, 126.2M.
Free cash flow1.12x
Its own average over 3 years, 409.6M.
Debt1.31x
Its own average over 3 years, 2.68B.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at 2.96 times.

Sales is 1.07 times its own 3-year average; Profit is 2.96 times its own 3-year average; Free cash flow is 1.12 times its own 3-year average; Debt is 1.31 times its own 3-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2026

Sales against its own 3-year average1.07
Source
computed
Statement
income
Fiscal year
2026
Reported in
CAD
Profit against its own 3-year average2.96
Source
computed
Statement
income
Fiscal year
2026
Reported in
CAD
Free cash flow against its own 3-year average1.12
Source
computed
Statement
income
Fiscal year
2026
Reported in
CAD
Debt against its own 3-year average1.31
Source
computed
Statement
income
Fiscal year
2026
Reported in
CAD
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
CAD